Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000, C544S245000, C544S249000, C544S250000, C514S247000, C514S256000, C514S257000
Reexamination Certificate
active
10852735
ABSTRACT:
Novel 1,3,4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives are disclosed. These compounds inhibit epidermal growth factor receptor (“EGFR”) tyrosine kinase. These compounds and their pharmaceutically acceptable salts and esters have antiproliferative activity and are useful, inter alia, in the treatment or control of cancer, in particular solid tumors. This invention also relates to pharmaceutical compositions containing such compounds and to methods of treating or controlling cancer, most particularly the treatment or control of breast, lung, colon and prostate tumors.
REFERENCES:
patent: 5610192 (1997-03-01), Cohen et al.
patent: 5747498 (1998-05-01), Schnur et al.
patent: 6548521 (2003-04-01), Cohen et al.
patent: 2002/0151557 (2002-10-01), Haddach et al.
patent: 0 566 226 (1993-10-01), None
patent: WO 96/30347 (1996-10-01), None
patent: WO 99/09016 (1999-02-01), None
patent: WO 99/55683 (1999-11-01), None
patent: WO 01/34574 (2001-05-01), None
Adjei A. A., Drugs of the Future, 2001, vol. 26(11): pp. 1087-1092.
Laird A. D. & Cherrington J. M., Expert Opin. Invetig. Drugs, 2003, vol. 12(1), pp. 51-64.
Laird A. D. & Cherrington J. M., supra; Adjey, supra; Drugs of the Future, 2002, vol. 27(4) pp. 339-345.
Myers, M. R. et al., Bioorganic & Medicinal Chemistry Letters, 1997, vol. 7(4), pp. 421-424.
Bridges A. J. et al., J. Med. Chem. 1996, vol. 39 pp. 267-276.
Rewcastle G. W. et al., J. Med. Chem., 1995, vol. 38, pp. 3482-3487.
Rusnak, D. W. et al., Cancer Research, American Association for Cancer Research Baltimore MD, US vol. 61 No. 19, Oct. 1, 2001, p. 7196-7203.
Traxler et al., Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 7, No. 6, 1997 p. 571-588.
Luk Kin-Chun
Zhang Zhuming
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
Phenalene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenalene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenalene derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753661